Literature DB >> 9178898

Cloning of human bone morphogenetic protein type IB receptor (BMPR-IB) and its expression in prostate cancer in comparison with other BMPRs.

H Ide1, M Katoh, H Sasaki, T Yoshida, K Aoki, Y Nawa, Y Osada, T Sugimura, M Terada.   

Abstract

Bone metastasis is a common event in prostate cancer, and it is known that some of the bone morphogenetic proteins (BMPs) are expressed in prostate cancer cells, while no study on the expression of their receptors, BMPRs, has been reported. Here we report cloning and sequence analysis of the human BMPR-IB cDNA. We also analysed the expression of transcripts of three types of the BMPR genes in human tissues and prostate cancer cell lines. The BMPR-IB mRNA was present in various organs, but the highest level was found in the prostate. Moreover, the amount of BMPR-IB mRNA was significantly low in prostate cancer tissues after androgen withdrawal and was also low in prostate cancer cell lines. RT-PCR analysis showed that the BMPR-IB message was upregulated by androgen stimulation in the LNCaP cell line which expresses the androgen receptor. By contrast, the mRNA levels of BMPR-IA and BMPR-II were not significantly different among non-cancerous and cancerous prostate tissues. It was also suggested that human BMPR-IA and BMPR-IB might have different biological functions in the prostate, although their sequences were 85.3% identical in the serine-threonine kinase domain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178898     DOI: 10.1038/sj.onc.1200964

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

Review 1.  The Yin and Yang of bone morphogenetic proteins in cancer.

Authors:  Ashok Singh; Rebecca J Morris
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-04       Impact factor: 7.638

2.  BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II.

Authors:  T Kirsch; J Nickel; W Sebald
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

3.  Insulin-like growth factor I suppresses bone morphogenetic protein signaling in prostate cancer cells by activating mTOR signaling.

Authors:  Reema S Wahdan-Alaswad; Kyung Song; Tracy L Krebs; Dorjee T N Shola; Jose A Gomez; Shigemi Matsuyama; David Danielpour
Journal:  Cancer Res       Date:  2010-11-09       Impact factor: 12.701

4.  The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors.

Authors:  Nam Y Lee; Kellye C Kirkbride; Richard D Sheu; Gerard C Blobe
Journal:  Mol Biol Cell       Date:  2009-09-02       Impact factor: 4.138

5.  Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2.

Authors:  Katarina Lehmann; Petra Seemann; Sigmar Stricker; Marai Sammar; Birgit Meyer; Katrin Süring; Frank Majewski; Sigrid Tinschert; Karl-Heinz Grzeschik; Dietmar Müller; Petra Knaus; Peter Nürnberg; Stefan Mundlos
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-01       Impact factor: 11.205

6.  Low expression of BMPRIB indicates poor prognosis of breast cancer and is insensitive to taxane-anthracycline chemotherapy.

Authors:  Kun Dai; Fengxia Qin; Huikun Zhang; Xiaoli Liu; Caixia Guo; Ming Zhang; Feng Gu; Li Fu; Yongjie Ma
Journal:  Oncotarget       Date:  2016-01-26

Review 7.  Specification of BMP Signaling.

Authors:  Joachim Nickel; Thomas D Mueller
Journal:  Cells       Date:  2019-12-05       Impact factor: 6.600

Review 8.  Hedgehog Signaling for Urogenital Organogenesis and Prostate Cancer: An Implication for the Epithelial-Mesenchyme Interaction (EMI).

Authors:  Taiju Hyuga; Mellissa Alcantara; Daiki Kajioka; Ryuma Haraguchi; Kentaro Suzuki; Shinichi Miyagawa; Yoshiyuki Kojima; Yutaro Hayashi; Gen Yamada
Journal:  Int J Mol Sci       Date:  2019-12-20       Impact factor: 5.923

9.  R-spondins are BMP receptor antagonists in Xenopus early embryonic development.

Authors:  Hyeyoon Lee; Carina Seidl; Rui Sun; Andrey Glinka; Christof Niehrs
Journal:  Nat Commun       Date:  2020-11-04       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.